Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study

PURPOSE: To study post-interventional findings in patients with dysthyroid optic neuropathy (DON) treated with teprotumumab. OBSERVATIONS: In this multicenter observational Case series, patients with DON were treated with teprotumumab, an insulin-like growth factor I receptor inhibitor (10 mg/kg for...

Descripción completa

Detalles Bibliográficos
Autores principales: Sears, Connie M., Wang, Yao, Bailey, Lucy A., Turbin, Roger, Subramanian, Prem S., Douglas, Raymond, Cockerham, Kimberly, Kossler, Andrea L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170359/
https://www.ncbi.nlm.nih.gov/pubmed/34113737
http://dx.doi.org/10.1016/j.ajoc.2021.101111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170359/
https://www.ncbi.nlm.nih.gov/pubmed/34113737
http://dx.doi.org/10.1016/j.ajoc.2021.101111

Ejemplares similares